Prognostic differences between atrial fibrillation and atrial flutter.
This report presents the outcome of a cohort of 94 patients with atrial fibrillation from the Canadian Registry of Atrial Fibrillation, in which we paid particular attention to the probability of stroke and death. We also evaluated warfarin use over time and compared left atrial dimensions in patients with atrial flutter with those with atrial fibrillation.
Lelorier
Paul
P
Division of Cardiology, University of Western Ontario, London, Ontario, Canada. paul.lelorier@bmc.org
Humphries
Karin H
KH
Krahn
Andrew
A
Connolly
Stuart J
SJ
Talajic
Mario
M
Green
Martin
M
Sheldon
Robert
R
Dorian
Paul
P
Newman
David
D
Kerr
Charles R
CR
Yee
Raymond
R
Klein
George J
GJ
D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000000981:diagnostic imaging / Q000401:mortality*; D001282:Atrial Flutter / Q000150:complications* / Q000000981:diagnostic imaging / Q000401:mortality*; D002170:Canada / Q000453:epidemiology; D015331:Cohort Studies; D005260:Female; D006325:Heart Atria / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D012042:Registries; D020521:Stroke / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D015996:Survival Rate; D014463:Ultrasonography; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin